-
4-(4-AMINOPHENYL)MORPHOLIN-3-ONE CAS:438056-69-0
4-(4-Aminophenyl)morpholin-3-one, often simplified for clarity, is a chemical compound recognized for its structural complexity and potential applications in medicinal chemistry. This compound integrates a morpholinone core with a substituted phenyl group, specifically an aminophenyl moiety, offering avenues for structural modifications and comprehensive biological investigations.
-
2-cyano-5-fluorobenzylbroMide CAS:421552-12-7
2-Cyano-5-fluorobenzyl bromide is a chemical compound belonging to the benzyl bromide family, characterized by a cyano group at position 2 and a fluorine atom at position 5 on the benzene ring. This structural configuration imbues the compound with specific chemical properties essential for its applications in organic synthesis and pharmaceutical chemistry. Benzyl bromides, in general, are crucial intermediates in the preparation of various organic compounds due to their versatile reactivity and functional group tolerance.
-
(S)-(+)-GLYCIDYL PHTHALIMIDE CAS:161596-47-0
(S)-(+)-Glycidyl Phthalimide, often referred to in abbreviated terms, is a chemically distinctive compound with notable relevance in organic synthesis and medicinal chemistry. This molecule combines a glycidyl group with a phthalimide moiety, and its stereochemistry plays a crucial role in its reactivity and applications. Its structural uniqueness allows for various modifications, making it a valuable scaffold for drug design and chemical research.
-
![3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester CAS:211915-84-3](https://cdn.globalso.com/xindaobiotech/VYH6FUCIIBE_I7B6OOPY286.png)
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester CAS:211915-84-3
3-[(3-Amino-4-methylamino-benzoyl)-pyridin-2-yl-amino]-propionic acid ethyl ester is a chemically intricate compound recognized for its complex molecular structure and potential pharmacological applications. This compound integrates a pyridine core with an amino-benzoyl group and an ethyl ester functionality, making it significant in medicinal chemistry and biochemical research due to its unique structural attributes and potential biological activities.
-
![2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS:865758-96-9](https://cdn.globalso.com/xindaobiotech/V3@A6KDXTE0I05WML222.png)
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS:865758-96-9
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]benzonitrile is a chemical compound notable for its complex structure derived from pyrimidine and benzonitrile moieties. This compound plays a significant role in medicinal chemistry and biochemical research due to its potential biological activities and structural attributes that influence molecular interactions within biological systems.
-
1-BROMO-2-BUTYNE CAS:3355-28-0
1-Bromo-2-butyne, a chemical compound classified under the alkyne group, features a bromine atom attached to the second carbon of a butyne chain. This structure imparts unique chemical reactivity and physical properties, making it valuable in various industrial and synthetic applications. Alkynes like 1-bromo-2-butyne are crucial intermediates in organic synthesis, offering pathways to diverse molecular structures through selective reactions.
-
(R)-3-Piperidinamine dihydrochloride CAS:334618-23-4
(R)-3-Piperidinamine dihydrochloride is a chemical compound recognized for its pivotal role as an intermediate in organic synthesis, particularly in pharmaceutical chemistry. This compound features a piperidine ring with an amino group at the 3rd position, stabilized by two chloride ions. Such structural attributes confer unique chemical properties that are instrumental in the development of various therapeutic agents and organic molecules.
-
HEXYL CHLOROFORMATE CAS:6092-54-2
Hexyl chloroformate is a chemical compound known for its versatile applications in organic synthesis and industrial processes. It belongs to the class of chloroformates, characterized by the presence of a chloroformate group (-OCOCl) attached to a hexyl chain. This compound plays a crucial role as a reagent in the modification of organic molecules and in the production of specialty chemicals.
-
5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde CAS:881677-11-8
5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde is a chemical compound recognized for its intricate molecular structure and potential applications in medicinal chemistry and organic synthesis. This compound combines a pyrrole core with a 2-fluorophenyl group and a pyridin-3-ylsulfonyl moiety, presenting unique opportunities for structural diversification and biological investigations.
-
Tetrahydropapaverine hydrochloride CAS:6429-4-5
Tetrahydropapaverine hydrochloride is a chemical compound studied in pharmaceutical research for its potential therapeutic applications. It is known for its pharmacological properties, particularly its impact on vascular smooth muscle and neurotransmitter systems. Researchers investigate its potential use in treating conditions such as hypertension and certain neurological disorders, aiming to harness its pharmacological profile for future clinical applications.
-
Ezetimibe INT A CAS:189028-95-3
Ezetimibe INT A is a pharmaceutical compound aimed at treating hyperlipidemia, characterized by elevated cholesterol levels. It inhibits intestinal absorption of cholesterol and related sterols by targeting the Niemann-Pick C1-like 1 (NPC1L1) protein, thereby reducing overall cholesterol levels in the bloodstream.
-
Pramipexole CAS:104632-26-0
Pramipexole is a dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It works by stimulating dopamine receptors in the brain, thereby improving motor symptoms in Parkinson’s disease and reducing the uncomfortable sensations in RLS. Pramipexole is available in both immediate-release and extended-release formulations, offering flexibility in treatment options for patients.’
